{"retracted":false,"update":{"timestamp":1430438400000,"doi":"10.1016/j.ejpn.2015.01.001","type":"err"},"doi":"10.1016/j.ejpn.2014.05.001","journal":"European Journal of Paediatric Neurology","publisher":"Elsevier BV","title":"Corrigendum to ‘efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies’ [YEJPN 18 (5) (2015) 641–645]"}
